Form 8.3

Summary by AI BETAClose X

Qube Research disclosed an opening economic exposure to Advanced Medical Solutions via 8,070,516 cash-settled derivatives representing 3.64% of the 5p ordinary share capital as at 10-11-2026, with 0 direct shares owned and 0 short positions; the filer reported increasing equity-swap long positions (19 at 282.50p and 31,314 at 283.00p) and stated there are 0 stock-settled derivatives, 0 subscription rights, no indemnities or voting/arrangement agreements, and no Supplemental Form 8 attached (disclosure dated 11-11-2026).

Disclaimer*

UK 100